Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2

Angiogenesis is a key event in the progression of gliomas. Exosomes, as signaling extracellular organelles, modulate the tumor microenvironment and promote angiogenesis and tumor progression. We previously demonstrated that long intergenic non-coding RNA CCAT2 (linc-CCAT2) was overexpressed in glioma tissues and functioned to promote glioma progression. Therefore, this study aimed to explore an underlying mechanism of glioma cell-affected angiogenesis. First, qRT-PCR was used to determine the expression level of linc-CCAT2 in 4 glioma cell lines and 293T cells, and the results revealed that the U87-MG cells exhibited the highest expression level. Subsequently, the pro-angiogenesis function of exosomes that were derived from negative control shRNA-treated U87-MG cells (ncU87-Exo) and linc-CCAT2 shRNA-treated U87-MG cells (shU87-Exo) was evaluated in vitro and in vivo. We found that ncU87-Exo, which was enriched in linc-CCAT2, could be taken up by HUVECs. ncU87-Exo improved the linc-CCAT2 expression level in HUVECs and more strongly promoted HUVEC migration, proliferation, tubular-like structure formation in vitro and arteriole formation in vivo as well as inhibited HUVEC apoptosis induced by hypoxia. Further mechanistic studies revealed that ncU87-Exo could upregulate VEGFA and TGFβ expression in HUVECs as well as promote Bcl-2 expression and inhibit Bax and caspase-3 expression. Finally, gain-/loss-of-function studies revealed that the overexpression of linc-CCAT2 in HUVECs activated VEGFA and TGFβ, promoted angiogenesis, promoted Bcl-2 expression and inhibited Bax and caspase-3 expression, thus decreasing apoptosis. Downregulation of linc-CCAT2 revealed the opposite effect. Thus, our results revealed a new exosome-mediated mechanism by which glioma cells could promote angiogenesis through the transfer of linc-CCAT2 by exosomes to endothelial cells. Moreover, we suggest that exosomes and linc-CCAT2 are putative therapeutic targets in glioma.

[1]  Igor Jurisica,et al.  The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. , 2006, Cancer research.

[2]  Leigh Coultas,et al.  Endothelial cell apoptosis in angiogenesis and vessel regression , 2017, Cellular and Molecular Life Sciences.

[3]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[4]  K. Camphausen,et al.  Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. , 2013, Translational oncology.

[5]  M. Hendrix,et al.  Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.

[6]  S. Raimondo,et al.  Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. , 2014, Cancer letters.

[7]  Raghu Kalluri,et al.  Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.

[8]  Lei Wu,et al.  Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells , 2016, Oncotarget.

[9]  Changqing Zhang,et al.  Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice , 2015, Stem Cell Research & Therapy.

[10]  Hui-Lung Sun,et al.  Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo. , 2010, Cancer letters.

[11]  M. Ye,et al.  Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. , 2015, Gene.

[12]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[13]  C. Kanduri,et al.  Long noncoding RNAs and neuroblastoma , 2015, Oncotarget.

[14]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[15]  Algire Gh.  Vascular reactions of normal and malignant tissues in vivo. VII. Observations on vascular reactions in destruction of tumor homografts. , 1954 .

[16]  A. Koster,et al.  Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing. , 2013, Nanomedicine.

[17]  Zhen Wang,et al.  Exosomes in tumor microenvironment: novel transporters and biomarkers , 2016, Journal of Translational Medicine.

[18]  Alberto Orfao,et al.  Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology. , 2010, Neuro-oncology.

[19]  M. Weiss,et al.  Long noncoding RNAs in biology and hematopoiesis. , 2013, Blood.

[20]  A. R. Fernandes,et al.  Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo , 2016, International journal of nanomedicine.

[21]  Michele Guescini,et al.  Astrocytes and Glioblastoma cells release exosomes carrying mtDNA , 2009, Journal of Neural Transmission.

[22]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[23]  CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA , 2015, Molecular Cancer.

[24]  A. Nicolas,et al.  Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets , 2015, BioMed research international.

[25]  Elisabetta Dejana,et al.  The Role of Wnt Signaling in Physiological and Pathological Angiogenesis , 2010, Circulation research.

[26]  X. Mei,et al.  Neuroprotective effect of rapamycin on spinal cord injury via activation of the Wnt/β-catenin signaling pathway , 2015, Neural regeneration research.

[27]  Hyoung-Pyo Kim,et al.  Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer , 2016, BMB reports.

[28]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[29]  N. Pećina-Šlaus.  Wnt signal transduction pathway and apoptosis: a review , 2010, Cancer Cell International.

[30]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[31]  F. Sánchez‐Madrid,et al.  Analysis of microRNA and protein transfer by exosomes during an immune synapse. , 2013, Methods in molecular biology.

[32]  J. Kitajewski,et al.  Wnt signaling in angiogenesis. , 2008, Current drug targets.

[33]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[34]  Anderson Chun On Tsang,et al.  Long non-coding RNA expression profiles predict clinical phenotypes in glioma , 2012, Neurobiology of Disease.

[35]  Timothy C Ryken,et al.  Toward precision medicine in glioblastoma: the promise and the challenges. , 2015, Neuro-oncology.

[36]  N. Tran,et al.  Isolation of small noncoding RNAs from human serum. , 2014, Journal of visualized experiments : JoVE.

[37]  Wen-Lang Lin,et al.  Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. , 2013, Genes & cancer.

[38]  Keith W. Vance,et al.  Transcriptional regulatory functions of nuclear long noncoding RNAs , 2014, Trends in genetics : TIG.

[39]  Yi Zhao,et al.  Identification and function annotation of long intervening noncoding RNAs , 2016, Briefings Bioinform..

[40]  I. Date,et al.  Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.

[41]  M. D. Simon,et al.  The Properties of Long Noncoding RNAs That Regulate Chromatin. , 2016, Annual review of genomics and human genetics.

[42]  Q. Yang,et al.  Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma , 2016, OncoTargets and therapy.

[43]  Jill S. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.

[44]  A. C. Marques,et al.  The miRNA-mediated cross-talk between transcripts provides a novel layer of posttranscriptional regulation. , 2014, Advances in genetics.

[45]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[46]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[47]  Y. Hida,et al.  Tumor angiogenesis—characteristics of tumor endothelial cells , 2016, International Journal of Clinical Oncology.

[48]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[49]  Ruman Rahman,et al.  Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma , 2010, Journal of oncology.

[50]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[51]  D. Ribatti,et al.  Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK‐STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model , 2014, British journal of haematology.

[52]  L. Yang,et al.  Long non-coding RNA Loc554202 expression as a prognostic factor in patients with colorectal cancer. , 2016, European review for medical and pharmacological sciences.

[53]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[54]  L. Sarian,et al.  Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation. , 2016, American journal of cancer research.

[55]  E. Chavakis,et al.  Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis , 2002, Arteriosclerosis, thrombosis, and vascular biology.